MY8500082A - Novel 7-halo-3,20-dioxo-1,4-pregnadienes and -4-pregnenes and their preparation - Google Patents

Novel 7-halo-3,20-dioxo-1,4-pregnadienes and -4-pregnenes and their preparation

Info

Publication number
MY8500082A
MY8500082A MY82/85A MY8500082A MY8500082A MY 8500082 A MY8500082 A MY 8500082A MY 82/85 A MY82/85 A MY 82/85A MY 8500082 A MY8500082 A MY 8500082A MY 8500082 A MY8500082 A MY 8500082A
Authority
MY
Malaysia
Prior art keywords
pregnadienes
pregnenes
dioxo
halo
novel
Prior art date
Application number
MY82/85A
Other languages
English (en)
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/753,257 external-priority patent/US4076708A/en
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of MY8500082A publication Critical patent/MY8500082A/xx

Links

Classifications

    • E—FIXED CONSTRUCTIONS
    • E04—BUILDING
    • E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
    • E04G11/00—Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs
    • E04G11/06—Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs for walls, e.g. curved end panels for wall shutterings; filler elements for wall shutterings; shutterings for vertical ducts
    • E04G11/20—Movable forms; Movable forms for moulding cylindrical, conical or hyperbolical structures; Templates serving as forms for positioning blocks or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0084—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkylene group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • E—FIXED CONSTRUCTIONS
    • E04—BUILDING
    • E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
    • E04G17/00—Connecting or other auxiliary members for forms, falsework structures, or shutterings
    • E04G17/14—Bracing or strutting arrangements for formwalls; Devices for aligning forms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Architecture (AREA)
  • Engineering & Computer Science (AREA)
  • Civil Engineering (AREA)
  • Mechanical Engineering (AREA)
  • Structural Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
MY82/85A 1976-12-22 1985-12-30 Novel 7-halo-3,20-dioxo-1,4-pregnadienes and -4-pregnenes and their preparation MY8500082A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75325676A 1976-12-22 1976-12-22
US05/753,257 US4076708A (en) 1976-12-22 1976-12-22 Process for the preparation of 7α-halogeno-3-oxo-4-dehydro steroids and novel 7α-halogeno derivatives produced thereby

Publications (1)

Publication Number Publication Date
MY8500082A true MY8500082A (en) 1985-12-31

Family

ID=27115720

Family Applications (1)

Application Number Title Priority Date Filing Date
MY82/85A MY8500082A (en) 1976-12-22 1985-12-30 Novel 7-halo-3,20-dioxo-1,4-pregnadienes and -4-pregnenes and their preparation

Country Status (20)

Country Link
JP (1) JPS604198B2 (no)
AR (1) AR226806A1 (no)
AT (2) AT373269B (no)
BE (1) BE862089A (no)
DE (1) DE2756550C2 (no)
DK (1) DK153494C (no)
FI (1) FI63947C (no)
FR (1) FR2384793A1 (no)
GB (1) GB1575983A (no)
HK (1) HK584A (no)
HU (1) HU179784B (no)
IE (1) IE45950B1 (no)
IL (1) IL53636A (no)
MY (1) MY8500082A (no)
NL (1) NL180479C (no)
NO (1) NO151826C (no)
NZ (1) NZ186031A (no)
PT (1) PT67432B (no)
SE (1) SE429865B (no)
SG (1) SG58683G (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109680036A (zh) 2017-10-02 2019-04-26 爱科来株式会社 糖化蛋白质的测定

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3429926A (en) * 1964-05-25 1969-02-25 Squibb & Sons Inc 7-halo and 6-halo,6-dehydro a-norprogesterones

Also Published As

Publication number Publication date
NL180479C (nl) 1987-03-02
DE2756550C2 (de) 1986-10-16
NL7714056A (nl) 1978-06-26
AR226806A1 (es) 1982-08-31
JPS5379850A (en) 1978-07-14
IL53636A (en) 1983-05-15
FI63947C (fi) 1983-09-12
ATA575980A (de) 1982-04-15
DE2756550A1 (de) 1978-07-06
DK153494C (da) 1989-02-20
BE862089A (fr) 1978-06-20
FR2384793A1 (fr) 1978-10-20
HU179784B (en) 1982-12-28
SE429865B (sv) 1983-10-03
JPS604198B2 (ja) 1985-02-01
IE45950L (en) 1978-06-22
PT67432B (en) 1979-05-23
ATA909477A (de) 1983-05-15
SG58683G (en) 1985-01-11
FR2384793B1 (no) 1981-11-13
FI63947B (fi) 1983-05-31
NO151826B (no) 1985-03-04
AT373269B (de) 1984-01-10
PT67432A (en) 1978-01-01
SE7714538L (sv) 1978-06-23
NL180479B (nl) 1986-10-01
DK153494B (da) 1988-07-18
IE45950B1 (en) 1983-01-12
AT377566B (de) 1985-04-10
NO151826C (no) 1985-06-12
HK584A (en) 1984-01-13
IL53636A0 (en) 1978-03-10
GB1575983A (en) 1980-10-01
FI773825A (fi) 1978-06-23
DK569977A (da) 1978-09-28
NO774359L (no) 1978-06-23
NZ186031A (en) 1984-07-31

Similar Documents

Publication Publication Date Title
JPS52105131A (en) Substituted phenylamidines and preparation thereof
IL60155A0 (en) Substituted phenoxybenzylalcohols and their preparation
ZA777158B (en) Polyfluoroallyloxy compounds,their preparation and copolymers therefrom
NZ184527A (en) Preparation of 6a,10a-transhexahydro-dibenzo-(b,d)pyran-9-ones
ZA777611B (en) Cyclopentan-1-amines and the preparation thereof
JPS52111552A (en) 44androstenee33one and preparation thereof
JPS5325565A (en) Novel aryltrifluoroethylamine and its preparation
IL51877A0 (en) Omega-nor-aromatic-13,14-dehydro-prostaglandins and process for their preparation
NZ184529A (en) 5-isopropylidene-7-hydroxy-9-substituted-2,6-methano-3,4,56-tetrahydro-2h-1-benzoxocins and their preparation
JPS52131534A (en) Aralkylarylamine and preparation thereof
IL52668A (en) 7 -amino-1-oxa-1-dethiacephalosporins and their preparation
IL52586A (en) O-ethyl-s-n-propyl-o-2,2,2,-trihaloethylphosphorothiolatesand-thionothiolates,their preparation and their use as inscticides,acraricides and nematocides
JPS5291859A (en) 22furanones and preparation thereof
JPS52100480A (en) Substituted ppaminophenyllasstriazinedione and its preparation
JPS5346977A (en) 55secondary alkylidenehydantoin and its preparation
GB1553321A (en) 1,2-epoxycholestene compounds their preparation and use
NZ184530A (en) Preparation of 6a, 10a-cis-hexahydrodil-benzopyranones
IL49823A0 (en) 1-acyl-1,2,3,4-tetrahydro-6-quinolinols and their preparation
IE44974L (en) Preparation of diaryl-alkylamines.
GB2030977B (en) 2,1-benzisothiazoles and preparation thereof
JPS5346960A (en) Biss22furanizylether and its preparation
ZA772274B (en) Substituted triazaadamantane compounds,preparation and use thereof
NZ184528A (en) Preparation of 6a,10a-cis-hexahydro-di-benzo-pyranones
JPS5291863A (en) Novel 22nitroimidazole derivatives and preparation thereof
HK584A (en) Novel 7-halo-3,20-dioxo-1,4-pregnadienes and-4-pregnenes and their preparation